中信证券：具备药险资源整合能力与技术壁垒的平台型公司 有望脱颖而出

Core Viewpoint - CITIC Securities believes that with the gradual clarification of the boundaries of basic medical insurance management, commercial insurance is expected to become the core incremental payment source in the healthcare industry, driven by policy dividends, data assets, and the iteration of commercial health insurance products [1] Group 1: Industry Trends - The next phase is expected to see commercial insurance comprehensive service providers addressing talent and data constraints at insurance companies, thereby unlocking structural bottlenecks faced by innovative pharmaceutical and medical device companies [1] - The industry is anticipated to enter a new development cycle of diversified payment systems in healthcare [1] Group 2: Investment Opportunities - The increasing penetration of commercial insurance payments and the maturation of cost control models driven by data intelligence are expected to favor platform companies with drug insurance resource integration capabilities and technological barriers, allowing them to emerge as industry leaders [1] - Three investment themes are suggested: 1. Platform companies empowering drug insurance collaboration, initiating a "gear shift upgrade" in the payment system [1] 2. Innovative pharmaceuticals and medical devices are likely to benefit from the incremental payment amounts brought by commercial health insurance and the enhancement of valuation systems [1] 3. Private medical terminals are set to welcome new payers, opening up future growth potential [1]